Skip to main content
. 2007 Jun 26;97(2):145–151. doi: 10.1038/sj.bjc.6603860

Figure 2.

Figure 2

Effects of CDA *3 on the pharmacokinetic parameters of gemcitabine. (A) Area under the curve (AUC) and (B) clearance (CL m−2). Each point corresponds to an individual patient. The bars denote the median values.